Ardigen's news feed
December 12, 2019
Share news in:

New microbiome and phenotype data from observational study will enlarge unique Ardigen’s database.

After two succeeded registrations of clinical studies at ClinicalTrial.gov, Ardigen finalized this process with next observational study: Microbiome Polish Map, NCT04169867. Ardigen, in cooperation with The Institute of Bioorganic Chemistry, Polish Academy of Sciences in Poznan, is building a unique set of scientific processed information describing the variability of the polish population microbiome.

A reliable dataset, which consists of 1000 healthy volunteers and 160 patients with melanoma treated with routine immunotherapy (anti-PD1, anti-PDL1 and/or anti CTLA4 antibodies), will characterize the gut microbiome diversity in the polish population. The collection of stool samples will be performed for each donor with information about eating habits and health survey. Samples will be sequenced by next-generation sequencing platform (Shotgun Metagenomics Seqensing).

The project is funded by Małopolskie Centre of Entrepreneurship (POIR.04.01.02-00-0025/17).

ClinicalTrials.gov is a resource which provides the public with easy access to information about clinical studies on a wide range of diseases and conditions conducted on human volunteers. This database is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH) in USA. 

 

Read more at:

https://clinicaltrials.gov/ct2/show/NCT04169867

December 03, 2019
New collaborations with hospitals in the area of clinical studies and data collection - press release
February, 3
Ardigen at PMWC 2020